Idera Pharmaceuticals stockholders sell shares, keeps 16.6% stake in company

By Lisa Kerner

Charlotte, N.C., Nov. 1 - Idera Pharmaceuticals, Inc. investors led by Julian C. Baker sold 148,570 shares of the company's stock priced from $11.69 to $12.46 each.

The shares were purchased between Oct. 29 and Oct. 31, according to a company news release.

The reporting persons beneficially own 3,828,703 shares, or 16.6%, of the Cambridge, Mass., biotechnology company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.